Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Nektar Therapeutics

4 Disclosed Funding Rounds $894,999,960

1 Participating Investments $18,000,000


Therapeutics, Chemical, Health Care, Biotechnology

Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.

San Carlos, California, United States, North America (US)

Organizations in San Carlos in Therapeutics,
Organizations in San Carlos in Chemical,
Organizations in San Carlos in Health Care,
Organizations in San Carlos in Biotechnology,
Organizations in California in Therapeutics,
Organizations in California in Chemical,
Organizations in California in Health Care,
Organizations in California in Biotechnology,
Organizations in United States in Therapeutics,
Organizations in United States in Chemical,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in North America in Therapeutics,
Organizations in North America in Chemical,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology

Investors in San Carlos in Therapeutics,
Investors in San Carlos in Chemical,
Investors in San Carlos in Health Care,
Investors in San Carlos in Biotechnology,
Investors in California in Therapeutics,
Investors in California in Chemical,
Investors in California in Health Care,
Investors in California in Biotechnology,
Investors in United States in Therapeutics,
Investors in United States in Chemical,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in North America in Therapeutics,
Investors in North America in Chemical,
Investors in North America in Health Care,
Investors in North America in Biotechnology

Silicon Valley (0 Investors) (0 Startups), West Coast (0 Investors) (0 Startups), Western US (0 Investors) (0 Startups), San Francisco Bay Area (0 Investors) (0 Startups)

Founded date 01, 1990

Founders John S. Patton

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Also known as Inhale Therapeutic Systems

Company Type For Profit


Twitter Link

LinkedIN Link

Wikipedia Link

Nektar Therapeutics is a biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. Nektar also partners with the top biopharmaceutical companies to bring new products to market. To date, Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.

Date Round Raised Lead
April, 03, 2018 Post-IPO Equity $849,999,960 -------
June, 02, 2016 Post-IPO Equity $20,000,000 -------
August, 28, 2013 Post-IPO Equity $25,000,000 AstraZeneca
January, 01, 2011 Post-IPO Equity Undisclosed -------

Nektar Therapeutics Participated In the Following Investment Rounds (1)

Organization Name Lead? Round Partners Participating Raise Date
Pearl Therapeutics Yes Series A ------- $18,000,000 July, 03, 2008

Nektar Therapeutics Investors (2)

Investor Lead? Round Participating Raise Date Partners
AstraZeneca Yes Post-IPO Equity $25,000,000 August, 28, 2013 -------
New Enterprise Associates No Post-IPO Equity Undisclosed January, 01, 2011 -------